Impact Factor 3.675

The 2nd most cited open-access journal in Endocrinology & Metabolism

Correction ARTICLE

Front. Endocrinol., 22 February 2018 | https://doi.org/10.3389/fendo.2018.00050

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

imageThomas Nyström1*, imageIrene Santos-Pardo1, imageFredric Hedberg1, imageJohan Wardell1, imageNils Witt1, imageYang Cao2,3, imageLeif Bojö4, imageBo Nilsson4 and imageJohan Jendle5
  • 1Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
  • 2Institution of Medical Sciences, Örebro University, Örebro, Sweden
  • 3Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
  • 4Central Hospital, Karlstad, Sweden
  • 5Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden

A corrigendum on

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
by Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, et al. Front Endocrinol (2017) 8:325. doi: 10.3389/fendo.2017.00325

One of the authors name, Irene Santos-Pardo, was misspelled in the published manuscript (as Irene Padro Santos). The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.

The original article was updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: longitudinal functional reserve index, liraglutide, subclinical heart failure, tissue Doppler echocardiography, type 2 diabetes

Citation: Nyström T, Santos-Pardo I, Hedberg F, Wardell J, Witt N, Cao Y, Bojö L, Nilsson B and Jendle J (2018) Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study. Front. Endocrinol. 9:50. doi: 10.3389/fendo.2018.00050

Received: 31 January 2018; Accepted: 05 February 2018;
Published: 22 February 2018

Edited and Reviewed by: Frontiers in Endocrinology Editorial Office, Frontiers, Switzerland

Copyright: © 2018 Nyström, Santos-Pardo, Hedberg, Wardell, Witt, Cao, Bojö, Nilsson and Jendle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Thomas Nyström, thomas.nystrom@sll.se